These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26377617)

  • 21. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of drug interactions relevant to pharmacodynamic indirect response models.
    Earp J; Krzyzanski W; Chakraborty A; Zamacona MK; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2004 Oct; 31(5):345-80. PubMed ID: 15669772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic model for chemotherapy-induced anemia in rats.
    Woo S; Krzyzanski W; Jusko WJ
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):123-33. PubMed ID: 17891399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic-pharmacodynamic modelling: history and perspectives.
    Csajka C; Verotta D
    J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):227-79. PubMed ID: 16404503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models.
    Krzyzanski W; Dmochowski J; Matsushima N; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):635-55. PubMed ID: 16941234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in mice.
    Krzyzanski W; Perez-Ruixo JJ; Harrold J
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):709-20. PubMed ID: 26341875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a source-to-outcome model for dietary exposures to insecticide residues: an example using chlorpyrifos.
    Hinderliter PM; Price PS; Bartels MJ; Timchalk C; Poet TS
    Regul Toxicol Pharmacol; 2011 Oct; 61(1):82-92. PubMed ID: 21722690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calculation of steady-state distribution delay between central and peripheral compartments in two-compartment models with infusion regimen.
    Wu G
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):259-64. PubMed ID: 12587955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analytical solution set for a four-compartment mixed mammillary/catenary model.
    Charkes ND; Siegel JA
    Nucl Med Commun; 1999 Jun; 20(6):575-80. PubMed ID: 10451871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-cycle times and the tumour control probability.
    Maler A; Lutscher F
    Math Med Biol; 2010 Dec; 27(4):313-42. PubMed ID: 19966342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition.
    Krzyzanski W; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):57-78. PubMed ID: 11253614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transit and lifespan in neutrophil production: implications for drug intervention.
    Câmara De Souza D; Craig M; Cassidy T; Li J; Nekka F; Bélair J; Humphries AR
    J Pharmacokinet Pharmacodyn; 2018 Feb; 45(1):59-77. PubMed ID: 29236223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
    Poulin P; Burczynski FJ; Haddad S
    J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A statistical model for functional mapping of quantitative trait loci regulating drug response.
    Gong Y; Wang Z; Liu T; Zhao W; Zhu Y; Johnson JA; Wu R
    Pharmacogenomics J; 2004; 4(5):315-21. PubMed ID: 15263889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A generalised age- and phase-structured model of human tumour cell populations both unperturbed and exposed to a range of cancer therapies.
    Basse B; Ubezio P
    Bull Math Biol; 2007 Jul; 69(5):1673-90. PubMed ID: 17361361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analytical calculation of protein production distributions in models of clustered protein expression.
    Feng H; Hensel Z; Xiao J; Wang J
    Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Mar; 85(3 Pt 1):031904. PubMed ID: 22587120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in rats.
    Kobuchi S; Ito Y; Hayakawa T; Nishimura A; Shibata N; Takada K; Sakaeda T
    J Pharmacol Toxicol Methods; 2014; 70(2):134-44. PubMed ID: 25072509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.